Read More
JENKINTOWN, PA, UNITED STATES, April 8, 2021 /EINPresswire.com/ — SFA Therapeutics, Inc., a clinical-stage biotechnology company, is pleased to announced the start…
Investors Meet Thirty of Top Startups in America-Angel Venture TUE, OCT 13 2020 9:00 AM—FRI, OCT 30 2020 4:00 PM SFA Therapeutics has been selected to present…
SFA Therapeutics was accepted into the highly competitive summer Y-Combinator Summer Cohort. Y-Combinator is an American seed money startup accelerator launched…
Read More
EcoSoul Home and SFA Therapeutics (1st place tie,) Read More
Funds are focused on Phase 1b clinical trial in psoriasis Read More
Abstract Patients who are carriers of the hepatitis B virus (HBV) are at high risk of chronic liver disease (CLD) which…
BIOTECH SHOWCASE: THE INVESTOR CONFERENCE FOR INNOVATORS Ira Spector, CEO of SFA Therapeutics will be presenting a corporate update at the…
Tales From the 2022 Biotech VC Fundraising Trail After the bonanza of 2021, life-sciences entrepreneurs reset their expectations as financing contracted…
SFA Therapeutics will begin testing of SFA001 in a Phase 1 exploratory trial at Einstein Hospital in Philadelphia 1Q 2023 Dr…
PROFILE A biotech CEO’s favorite ‘F’ word At SFA Therapeutics, patients are the “focus” of Ira Spector’s approach to changing the…
PODCAST Treat Disease, Not the Symptoms In this podcast, Dr. Ira Spector discusses how his career journey has epitomized the ability…
Med Tech Gurus Developing The Next Big Thing Ira Spector Co-Founder & CEO of SFA Therapeutics delivers a master class in innovation and…
Abstract Cancer is a multi-step process that can be viewed as a cellular and immunological shift away from homeostasis in response…
JENKINTOWN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) — SFA Therapeutics, a clinical-stage biotech using a first-in-class immuno-modulation technology platform, announced positive results…
SFA-002 Updated Extension Data Showing 92% PASI 50 and 72% PASI 75 $4.5 Million Bridge Financing led by North South Ventures Composition…
Ben Franklin Healthcare Investments Invests $1.3 Million in Four Companies Ben Franklin Healthcare Investments continues support of SFA Therapeutics with…
JENKINTOWN, Pa., May 2, 2024 /PRNewswire/ — SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for the treatment of inflammatory…
In this article, senior leaders at SFA Therapeutics emphasise the importance of re-establishing homeostasis in drug development approaches. The Promise…
